Medicine Access Seminar 2026
15 August 2026 - Putrajaya Marriott Hotel
8/16/20262 min read
Medicine Access Seminar 2026 Convenes National Stakeholders on Sustainable Access to Innovative Medicines
WP Putrajaya, 15 August 2026
The Medicine Access Seminar 2026 convened 96 participants representing 63 institutions across 13 states — including policymakers and officers from the Ministry of Health, clinicians from public hospitals, academic researchers, and industry representatives — to examine a central question for Malaysia's health system: how access to innovative medicines can be financed sustainably and equitably.
Guided by the theme "Malaysia Access Model: Are We There Yet?", the programme examined the current state of the national access model and the mechanisms that will shape its evolution. Sessions addressed hybrid and innovative financing models, outcome-based agreements, and financing approaches for high-cost therapies, complemented by an international perspective on Brazil's health financing reforms — offering comparative insights from a middle-income health system navigating similar tensions between innovation adoption and fiscal sustainability. Faculty were drawn from the Ministry of Health, Universiti Malaya, Universiti Sains Malaysia, Monash University Malaysia, and Hospital Kuala Lumpur, together with international speakers.
Three themes emerged from the proceedings:
Sustainable financing as a prerequisite for access. Consistent with the conclusions of MySPOR's 2024 forum on the Medicine Access Scheme (MASc), participants affirmed that innovative access mechanisms achieve their fullest impact when anchored within a sustainable national health financing framework.
Evidence as the foundation of value-based decision making. As Malaysia advances toward value-based healthcare, rigorous health economics and outcomes research is increasingly central to listing, pricing, and reimbursement decisions.
Multi-stakeholder collaboration as the operating model. Sustainable access requires coordinated engagement across regulators, payers, providers, academia, and industry; no single stakeholder can deliver it independently.
The seminar reflects MySPOR's commitment to advancing health economics and outcomes research excellence to inform healthcare decision making in Malaysia. As the health system enters a period of significant reform — encompassing new financing instruments, payment models, and assessment frameworks — the Society will continue to serve as a neutral platform for evidence-based dialogue: convening stakeholders, strengthening HEOR capability, and supporting the development of policies that promote healthcare that is accessible, effective, efficient, and affordable for all Malaysians.
To stay informed of upcoming MySPOR events and HEOR insights, subscribe to our newsletter.